Successful application of сytokinetic therapy in the treatment of disseminated breast cancer (case report)
Background. Luminal B breast cancer is characterized by a worse prognosis and a higher risk of recurrence compared to luminal A. Unlike subtype A, it has a higher mutational load and PD-L1 expression, making it potentially sensitive to immunotherapy, including cytokine therapy. Objective. To evaluate the efficacy and s...